AC Immune Ltd (ACIU) — Capital Reinvestment Ratio
Latest as of December 2024:
0.02x
AC Immune Ltd (ACIU) has a Capital Reinvestment Ratio of 0.02x as of December 2024, meaning it reinvests 0% of its operating cash flow ($5.93 Million) in capital expenditures ($90.00K). Check ACIU goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
$5.93 Million
USD
Capital Expenditures
$90.00K
USD
Data as of
Dec 2024
Most recent filing
AC Immune Ltd Capital Reinvestment Ratio (2015–2024)
This chart tracks AC Immune Ltd's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see ACIU cash flow metrics.
Annual Capital Reinvestment Ratio for AC Immune Ltd (2015–2024)
Year-by-year Capital Reinvestment Ratio for AC Immune Ltd from 2015 to 2024. See ACIU free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | $65.84 Million | $576.00K | ▼ -74.4% |
| 2019 | 0.03x | $55.22 Million | $1.89 Million | ▲ +516.7% |
| 2015 | 0.01x | $44.08 Million | $244.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow